Pulmonology💬 Generalbronchiectasispseudomonasinhaled-antibiotics
Non-CF bronchiectasis with chronic Pseudomonas colonization — inhaled vs IV antibiotics and airway clearance?
Prabhu Kvn
Other
👁 24 views💬 1 answers🕐 Apr 14, 2026
58F with post-TB bronchiectasis, multiple bilateral dilated airways on HRCT, baseline FEV1 55%. She has been chronically colonized with Pseudomonas aeruginosa (2 sputum cultures positive 3 months apart). She has 3-4 exacerbations per year requiring oral antibiotics. BSI score is 9 (severe). ERS 2017 bronchiectasis guidelines recommend regular airway clearance and consideration of long-term antibiotics. Should I start inhaled colistin or tobramycin? When would IV pip-tazo be needed? What airway clearance device/technique is most effective?
Per ERS 2017 Bronchiectasis Guidelines — this patient with BSI 9 (severe), chronic Pseudomonas colonization, and 3-4 exacerbations/year is a high-priority case: **1. Long-term Inhaled Antibiotics (first choice for chronic Pseudomonas):** - **Colistimethate sodium (Promixin/Colobreathe):** Approved in EU for bronchiectasis with chronic P. aeruginosa. 1 million units BD via I-neb nebulizer. - **Tobramycin (TOBI Podhaler):** FDA-approved for CF, used off-label in non-CF bronchiectasis. 300mg BD in 28-day on/off cycles. - Both are equally effective; choice based on local availability, patient preference, cost. - Evidence: Inhaled aztreonam and ciprofloxacin DPI also studied but not consistently superior to inhaled colistin/tobramycin. **2. Long-term Oral Antibiotics:** - **Azithromycin 250mg 3x/week** or **500mg 3x/week**: ERS guideline recommendation for patients with ≥3 exacerbations/year. Reduces exacerbation frequency by ~30%. Monitor for QTc prolongation and NTM screening before starting. - **Dual therapy:** Inhaled + oral macrolide combination often used in severe cases. **3. When is IV Antibiotics (Pip-Tazo/Meropenem) indicated?** - Acute severe exacerbation with: - Systemic sepsis signs (fever, WBC elevation, CRP >100) - Failure of oral antibiotics after 48-72h - Hospitalization required - Use sensitivity-guided IV antibiotics; Pseudomonas coverage: Pip-Tazo 4.5g TDS or Meropenem 1g TDS x 14-21 days - Combination therapy (e.g., beta-lactam + aminoglycoside) for severe/MDR Pseudomonas **4. Airway Clearance (Critical Component):** - **ACBT (Active Cycle of Breathing Technique):** Evidence-based first-line, simple, no device needed. BD-TDS sessions. - **Oscillating PEP devices (Acapella, Flutter, Aerobika):** Help loosen secretions + drainage. Preferred if secretions are thick. - **High-frequency chest wall oscillation (Vest therapy):** Useful for patients unable to perform ACBT independently. - **Hypertonic saline (7%) nebulization:** Improves sputum clearance; use before airway clearance session. - **Pulmonary rehabilitation:** Improves exercise capacity and exacerbation frequency. **Monitoring:** Annual sputum MCS, spirometry, HRCT every 2-3 years to assess progression.
Be specific. Your credentials will be shown with your answer.